Inhibition of spleen tyrosine kinase attenuates allergen-mediated airway constriction.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Respiratory Cell and Molecular Biology

• Publication date

  2013-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1165/rcmb.2013-0200OCPMID 23889698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bronchial Asthma: The Possible Role of the Chemical Mediators of Immediate Hypersensitivity in the Pathogenesis of Subacute Chronic Disease1, 2

  2015cited by this paper
• Effect of locally administered Syk siRNA on allergen-induced arthritis and asthma.

  2013cited by this paper
• Spleen tyrosine kinase inhibition attenuates airway hyperresponsiveness and pollution-induced enhanced airway response in a chronic mouse model of asthma.

  2013cited by this paper
• Characterization of a model of tracheal plasma extravasation in passively sensitized rats using anti-allergic and anti-inflammatory drugs by oral and intratracheal route.

  2012cited by this paper
• Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• Comprehensive analysis of kinase inhibitor selectivity

  2011cited by this paper
• Navigating the kinome.

  2011cited by this paper
• Recent advances in the pathophysiology of asthma.

  2010cited by this paper
• The SYK tyrosine kinase: a crucial player in diverse biological functions

  2010cited by this paper
• New therapies for asthma: is there any progress?

  2010cited by this paper
• Modeling of asthma, COPD and cystic fibrosis in sheep.

  2008cited by this paper
• Allergen inhalation challenge: a human model of asthma exacerbation.

  2007cited by this paper
• The Expanding Role for ITAM-Based Signaling Pathways in Immune Cells

  2007cited by this paper
• Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness.

  2006cited by this paper
• Temporal profile of forced expiratory lung function in allergen-challenged Brown-Norway rats.

  2006cited by this paper
• Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation.

  2006cited by this paper
• Spleen tyrosine kinase (Syk) as a novel target for allergic asthma and rhinitis

  2005cited by this paper
• Mast Cells, FcεRI, and IL-13 Are Required for Development of Airway Hyperresponsiveness after Aerosolized Allergen Exposure in the Absence of Adjuvant1

  2004cited by this paper
• The Orally Available Spleen Tyrosine Kinase Inhibitor 2-[7-(3,4-Dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide Dihydrochloride (BAY 61-3606) Blocks Antigen-Induced Airway Inflammation in Rodents

  2003cited by this paper
• G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells.

  2003cited by this paper
• Piceatannol, a Syk-selective tyrosine kinase inhibitor, attenuated antigen challenge of guinea pig airways in vitro.

  2002cited by this paper
• Characterization of lung hyperresponsiveness, inflammation, and alveolar macrophage mediator production in allergy resistant and susceptible rats.

  2002cited by this paper
• Pharmacology of N-(3,5-dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline carboxamide (SCH 351591), a novel, orally active phosphodiesterase 4 inhibitor.

  2002cited by this paper
• Inhibition of Allergic Inflammation in the Airways Using Aerosolized Antisense to Syk Kinase1

  2002cited by this paper
• FcεRI-Dependent Signaling Pathways in Human Mast Cells

  2001cited by this paper
• Immediate allergic response in small airways.

  2001cited by this paper
• Fc(epsilon)Ri-dependent signaling pathways in human mast cells.

  2001cited by this paper
• The health economics of asthma and rhinitis. I. Assessing the economic impact.

  2001cited by this paper
• Aerosolized Syk Antisense Suppresses Syk Expression, Mediator Release from Macrophages, and Pulmonary Inflammation1

  2000cited by this paper
• Reducing IgE levels as a strategy for the treatment of asthma.

  2000cited by this paper
• The effect of montelukast (MK‐0476), a cysteinyl leukotriene receptor antagonist, on allergen‐induced airway responses and sputum cell counts in asthma

  1999cited by this paper
• The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects.

  1997cited by this paper
• Development of Eosinophilic Airway Inflammation and Airway Hyperresponsiveness in Mast Cell–deficient Mice

  1997cited by this paper
• Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices.

  1996cited by this paper
• Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells.

  1996cited by this paper
• Airway and tissue behavior during early response in sensitized rats: role of 5-HT and LTD4.

  1996cited by this paper
• T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure.

  1995cited by this paper
• Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep.

  1994cited by this paper
• In vitro allergic bronchoconstriction in the brown Norway rat.

  1994cited by this paper
• Responsiveness of individual airways to methacholine in adult rat lung explants.

  1993cited by this paper
• ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain.

  1992cited by this paper
• ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain

  1992cited by this paper
• Neurogenic inflammation, vascular permeability, and mast cells. Capsaicin desensitization fails to influence IgE-anti-DNP induced vascular permeability in rat airways.

  1990cited by this paper
• A new instrument for the rapid preparation of tissue slices.

  1980cited by this paper
• Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease.

  1975cited by this paper
• The effect of disodium cromoglycate on the release of histamine and degranulation of rat mast cells induced by compound 48-80.

  1971cited by this paper
• Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone.

  1971cited by this paper
• COMPARISON OF AN ANTISEROTONIN (CYPROHEPTADINE) AND A PURE ANTIHISTAMINE CHLORPHENIRAMINE) IN HAY FEVER

  1962cited by this paper
• Prophylactic treatment of migraine headache and histamine cephalalgia with a serotonin antagonist (methysergide).

  1961cited by this paper
• Prophylactic treatment of migraine headache and histamine cephalalgia with a serotonin antagonist (methysergide).

  1961cited by this paper

• Safety, tolerability, pharmacokinetics and pharmacodynamics of the spleen tyrosine kinase inhibitor BI 894416 in healthy volunteers and patients with asthma.

  2026cites this paper
• Optimal molecular binding data and pharmacokinetic profiles of novel potential triple-action inhibitors of chymase, spleen tyrosine kinase, and prostaglandin D2 receptor in the treatment of asthma

  2023cites this paper
• Perilla Leaf Extract Attenuates Asthma Airway Inflammation by Blocking the Syk Pathway

  2021cites this paper
• IgE and mast cells: The endogenous adjuvant.

  2020cites this paper
• Estimation of Fraction Dissolved After Intratracheal Delivery of a Potent Janus Kinase Inhibitor, iJAK-001, with Low Solubility in Rat and Sheep: Impact of Preclinical PKPD on Inhaled Human Dose Projection

  2019influential citation
• Characterizing Pharmacokinetic–Pharmacodynamic Relationships and Efficacy of PI3Kδ Inhibitors in Respiratory Models of TH2 and TH1 Inflammation

  2019cites this paper
• Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis

  2018cites this paper
• Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights

  2018cites this paper
• Inhibition of spleen tyrosine kinase attenuates IgE‐mediated airway contraction and mediator release in human precision cut lung slices

  2016cites this paper
• Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease

  2016cites this paper
• Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation

  2016cites this paper
• Carboxamide Spleen Tyrosine Kinase (Syk) Inhibitors: Leveraging Ground State Interactions To Accelerate Optimization.

  2016cites this paper
• Antiallergische und antientzündliche Pharmakotherapie

  2016cites this paper
• T cell tyrosine phosphorylation response to transient redox stress.

  2015cites this paper
• Discovery and profiling of a selective and efficacious Syk inhibitor.

  2015cites this paper
• Dietary Compound Kaempferol Inhibits Airway Thickening Induced by Allergic Reaction in a Bovine Serum Albumin-Induced Model of Asthma

  2015cites this paper
• IgE and Mast Cells: The Endogenous Adjuvant.

  2015cites this paper
• Orally bioavailable Syk inhibitors with activity in a rat PK/PD model.

  2015cites this paper
• Anti-IgE therapy: clinical utility and mechanistic insights.

  2015cites this paper
• Development and pharmacological validation of novel methods of B cell activation in rat whole blood.

  2015cites this paper
• A novel inhaled Syk inhibitor blocks mast cell degranulation and early asthmatic response.

  2015cites this paper
• Overcoming mutagenicity and ion channel activity: optimization of selective spleen tyrosine kinase inhibitors.

  2015cites this paper
• Immunoglobulin E signal inhibition during allergen ingestion leads to reversal of established food allergy and induction of regulatory T cells.

  2014influential citation
• SYK is a critical regulator of FLT3 in acute myeloid leukemia.

  2014cites this paper
• Syk inhibitors with high potency in presence of blood.

  2014cites this paper
• Small-molecule inhibitors of spleen tyrosine kinase as therapeutic agents for immune disorders: will promise meet expectations?

  2014cites this paper
• Syk mediates airway contractility independent of leukocyte function

  2013cites this paper